Brain simulation device
Neurovalens has raised €22M across 5 funding rounds from 10 investors, most recently a round in Aug 2025. Based in Belfast, Ireland; active in Healthtech. Data as of 6 Aug 2026.
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors |
|---|
| 2025-08-20 | Other | €6.9M | Angel Co-Fund,Innovation Ulster,Investment Fund for Northern Ireland (IFNI),IQ Capital,Whiterock | View deal → |
| 2024-04-08 | Other | €2.4M | Existing investors | View deal → |
| 2020-07-20 | Other | €5.6M | IQ Capital | View deal → |
| 2019-01-01 | Series A | €5.4M | Wharton Asset Management | View deal → |
| 2017-06-20 | Seed | €1.3M | Angel CoFund,Beltrae Partners,techstart NI | View deal → |
